Asmanex
Product Images NDC 54868-5547

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Asmanex (NDC 54868-5547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (220 mcg package label)

Label for Asmanex Twist 220 MCG inhaler from Physicians Total Care, Inc. showing product NDC 54868-5547-1, lot number 0000, and an expiration date of 01/60. Includes barcode and distributor information with location Tulsa, OK.*

FDA Label Image

Chemical Structure (Asmanex 01)

Chemical structure of the active ingredient associated with Asmanex, showing a complex steroid backbone with chlorine, hydroxyl, and ester functional groups, including a furan ring.*

FDA Label Image

Figure (Asmanex 02)

A line graph showing a 12-week trial comparing mean change in FEV1 (liters) between Asmanex 220 mcg QD PM (N=100) and placebo (N=95) in patients previously maintained on inhaled beta-2 agonists. The graph shows greater improvement in FEV1 for Asmanex versus placebo over time, with statistically significant differences noted (p<.05).*

FDA Label Image

Figure (Asmanex 03)

A line graph titled 'Figure 2: A 12-Week Trial in Patients Previously Maintained on Inhaled Corticosteroids,' showing mean change in FEV1 (L) over 12 weeks and at endpoint for Asmanex 220 mcg QD PM, Asmanex 440 mcg QD PM, Asmanex 220 mcg BID, and placebo. The graph compares the efficacy of these treatments with statistical significance noted between Asmanex Twisthaler and placebo.*

FDA Label Image

Figure (Asmanex 04)

A line graph titled 'A 12-Week Trial in Children 4 to 11 Years of Age: % Predicted FEV1 Change from Baseline Over Time and at Endpoint by Treatment Group' comparing placebo and Asmanex 110 mcg QD PM. The x-axis shows time points from baseline to week 12 and endpoint, while the y-axis shows the mean change in % predicted FEV1. The graph illustrates an increasing trend in FEV1 for Asmanex compared to placebo over the 12 weeks.*

FDA Label Image

Figure (Asmanex 05)

Illustration of the Asmanex inhaler by Physicians Total Care, Inc. Two views are shown: one of the inhaler in the upright position labeled with cap, dose counter, and base; and another with the cap removed labeling the mouthpiece and indented arrow. The inhaler is white with a gray base and cap.*

FDA Label Image

Figure (Asmanex 06)

An instructional diagram showing how to hold and open an Asmanex inhaler. It directs the user to hold the inhaler upright and twist the cap counterclockwise to open, explaining that removing the cap loads the dose. Key parts are labeled, including the cap and ventilation hole.*

FDA Label Image

Figure (Asmanex 07)

An instructional grayscale illustration showing a woman using an inhaler with an attached spacer. The diagram highlights the ventilation holes on the spacer and instructs not to cover them while inhaling the dose. The image serves as a guide for correct inhalation technique using the device.*

FDA Label Image

Figure (Asmanex 08)

Instructional diagrams showing how to properly close the Asmanex inhaler by Physicians Total Care, Inc. The first image illustrates aligning the indented arrow with the dose counter and turning the cap clockwise until a "click" sound is heard. The second image confirms the inhaler is fully closed when the click is audible, indicating the next dose is properly loaded.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.